Teva Pharmaceutical Industries, Ltd.: all 671 studies
Page 7 of 7. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® AloneCompletedNCT00240006Phase 4
- A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®CompletedNCT00239993Phase 4
- A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® TherapyCompletedNCT00238654
- Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough PainCompletedNCT00236145Phase 3
- Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe PsoriasisCompletedNCT00236119Phase 2
- Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough PainCompletedNCT00236093Phase 2
- A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety DisorderCompletedNCT00236067Phase 3
- A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety DisorderCompletedNCT00236054Phase 3
- Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)CompletedNCT00236041Phase 2
- A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety DisorderCompletedNCT00236015Phase 3
- Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety DisorderCompletedNCT00233675Phase 3
- Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic AsthmaCompletedNCT00232999Phase 2
- Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough PainCompletedNCT00228605Phase 3
- Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHDCompletedNCT00228540Phase 3
- A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.CompletedNCT00220922Phase 4
- Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.CompletedNCT00214994Phase 3
- Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHDCompletedNCT00214981Phase 3
- Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive SleepinessCompletedNCT00214968Phase 3
- Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough PainCompletedNCT00214955Phase 3
- Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough PainCompletedNCT00214942Phase 3
- Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.CompletedNCT00203177Phase 3
- Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease PatientsCompletedNCT00203164Phase 3
- A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of LupusTerminatedNCT00203151Phase 2
- Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's DiseaseCompletedNCT00203138Phase 3
- A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study.CompletedNCT00203125Phase 3
- Safety and Efficacy Study of Copaxone Administered in Combination With MinocyclineCompletedNCT00203112Phase 2
- Safety and Efficacy Study of Copaxone Administered in Combination With N-AcetylcysteineCompletedNCT00203099Phase 2
- A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple SclerosisCompletedNCT00203086
- A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.CompletedNCT00203073Phase 2
- Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With LevodopaCompletedNCT00203060Phase 3
- Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor FluctuationsCompletedNCT00203034Phase 3
- A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of MelanomaCompletedNCT00203008
- Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMSTerminatedNCT00202995Phase 4
- A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved DoseCompletedNCT00202982Phase 2
- Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive BladderCompletedNCT00196404Phase 2
- A Trial to Evaluate DR-2021 in Women With Secondary AmenorrheaCompletedNCT00196391Phase 2
- A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal AtrophyCompletedNCT00196378Phase 3
- A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic PainCompletedNCT00196365Phase 3
- A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.CompletedNCT00196352Phase 3
- A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer PatientsCompletedNCT00196339Phase 2
- Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL)TerminatedNCT00151736Phase 2
- Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to RituximabCompletedNCT00139841Phase 3
- Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic PainCompletedNCT00117481Phase 2
- Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase ReplacementCompletedNCT00117468Phase 2
- A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive RegimensCompletedNCT00117273Phase 3
- Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral DensityWithdrawnNCT00117260Phase 3
- Comparison of Two Bronchodilator Inhalers in Pediatric AsthmaticsCompletedNCT00112411Phase 2
- Evaluation of Two Doses of QVAR Versus Placebo by Breath Operated and Metered Dose Inhalers in Moderate Asthmatic Adolescents and Adults on a Stable Regimen of Inhaled CorticosteroidsCompletedNCT00109668Phase 3
- PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea SyndromeCompletedNCT00107848Phase 3
- Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea SyndromeCompletedNCT00107809Phase 3
- Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With NarcolepsyCompletedNCT00107796Phase 3
- OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer PatientsCompletedNCT00105937Phase 3
- Treatment of Breakthrough Pain in Opioid Tolerant Cancer PatientsCompletedNCT00105287Phase 3
- Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)CompletedNCT00104273Phase 2
- Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain TumorsCompletedNCT00104091Phase 2
- Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic ChildrenCompletedNCT00094016Phase 3
- Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced AsthmaCompletedNCT00085774Phase 3
- Study of CEP-701 in Treatment of Prostate CancerCompletedNCT00081601Phase 2
- Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML)CompletedNCT00079482Phase 2
- SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)CompletedNCT00076349Phase 2
- Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult PatientsTerminatedNCT00071552Phase 4
- Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain TumorsCompletedNCT00071539Phase 2
- Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's LymphomaCompletedNCT00069758Phase 2
- Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade GliomasTerminatedNCT00062504Phase 2
- Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler TechniqueCompletedNCT00054964Phase 2
- Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's DiseaseTerminatedNCT00040404Phase 2/3
- Effects of Talampanel on Patients With Advanced Parkinson's DiseaseCompletedNCT00036296Phase 1/2
- Multicenter Trial For Patients With Acute Crohn's DiseaseCompletedNCT00035503Phase 2
- Multicenter Trial for Adults With Partial SeizuresCompletedNCT00034814Phase 2
- Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 MutationCompletedNCT00030186Phase 2
- Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate CancerCompletedNCT00005623Phase 3
← Teva Pharmaceutical Industries, Ltd. overview and focus areas